| PABD | predeposit autologous blood donation |
|---|---|
| CDI | cell-directed inhibitor; central or chronic diabetes insipidus; Children's Depression Inventory; col... |
| DAD | delayed afterdepolarization; diffuse alveolar damage; dispense as directed |
| DSUH | directed suggestion under hypnosis |
| MEDIHC | Military Experience Directed Into Health Careers |
| ABD | Autologous blood donation |
|---|---|
| PABD | Preoperative autologous blood donation |
| PAD | Preoperative autologous donation |
| ADEPT | Antibody Directed Enzyme Prodrug Therapy |
| GDEPT | Gene directed enzyme prodrug therapy |
| oocyte donation | <gynaecology> Transfer of egg cell from donor to host mother. Oocytes are captured by laparoscopy, fertilised in vitro, and transferred to the recipient. Used for women with premature ovarian failure or severe genetic disorders, women who respond poorly to human menopausal gonadotropin, and women older than 40 years who do not conceive with use of other therapies. (21 Jun 2000) |
|---|---|
| egg donation | Donation of an ovum by one woman to another who attempts to become pregnant by in vitro fertilization. (09 Oct 1997) |
| Antibody Directed Enzyme Prodrug Therapy | <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately. The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects. Acronym: ADEPT (14 Nov 1997) |
| RNA-directed DNA polymerase | <enzyme> An enzyme that synthesises DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. Chemical name: Deoxynucleotide-triphosphate:DNA deoxynucleotidyltransferase (RNA-directed) Registry number: EC 2.7.7.49 (12 Dec 1998) |
| mutagenesis, site-directed | Mutagenesis where the mutation is caused by in vitro induction directed at a specific site in a DNA molecule. The most common method involves use of a chemically synthesised oligonucleotide mutant which can hybridise with the DNA target molecule. The resulting mismatch-carrying DNA duplex may then be transfected into a bacterial cell line and the mutant strands recovered. (12 Dec 1998) |
| site-directed mutagenesis | <molecular biology> Any of several methods used to create specific alterations in a gene. (09 Oct 1997) |
| directed molecular evolution | Techniques used to produce molecules exhibiting properties that conform to the demands of the experimenter. (12 Dec 1998) |
| DNA-directed DNA polymerase | <enzyme> DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. Chemical name: Deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) Registry number: EC 2.7.7.7 (12 Dec 1998) |
| DNA-directed RNA polymerase | <enzyme> A group of enzymes that catalyses DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesised. Chemical name: Nucleoside-triphosphate:RNA nucleotidyltransferase (DNA-directed) Registry number: EC 2.7.7.6 (12 Dec 1998) |
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|